News : Igi, 12 Jul 2025

Near-term upsides from deal with AbbVie may be priced in Glenmark’s stock
Igi

Near-term upsides from deal with AbbVie may be priced in Glenmark’s stock

Posted on
Read More
Glenmark Pharma shares cool off after hitting 20% upper circuit post mega ISB 2001 deal
Igi

Glenmark Pharma shares cool off after hitting 20% upper circuit post mega ISB 2001 deal

Posted on
Read More
Glenmark Pharma shares surge 10%, hit upper circuit limit
Igi

Glenmark Pharma shares surge 10%, hit upper circuit limit

Posted on
Read More
Glenmark Pharma among 8 stocks that hit 52-week highs, rally up to 35% in a month
Igi

Glenmark Pharma among 8 stocks that hit 52-week highs, rally up to 35% in a month

Posted on
Read More
A $2 billion shot in the arm: Why Glenmark’s AbbVie deal could trigger rerating
Igi

A $2 billion shot in the arm: Why Glenmark’s AbbVie deal could trigger rerating

Posted on
Read More
Glenmark Pharma share price hits 10% upper circuit on unit’s cancer licensing deal with AbbVie
Igi

Glenmark Pharma share price hits 10% upper circuit on unit’s cancer licensing deal with AbbVie

Posted on
Read More